Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.
Sacred Heart Health System, Pensacola, Florida, United States
New York University Medical Center, New York, New York, United States
Baptist Medical Center, South, Montgomery, Alabama, United States
Keck School of Medicine, University of Southern California, Los Angeles, California, United States
Emory Hospital, Atlanta, Georgia, United States
International Heart Institute, Missoula, Montana, United States
Cardio-Thoracic Surgeons, PC, Birmingham, Alabama, United States
St Vincent Medical Center, Los Angeles, California, United States
Memorial Herman Memorial City Hospital, Houston, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.